Bio-RadBIO.B
NYSELaboratory Instruments
No cached AI snapshot yet for BIO.B.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
7,450 employees26.99M shares outstandinglisted 1899-12-30
Next earnings ~May 5, 2026
About Bio-Rad
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Latest News
Showing market-wide stock news
Stock Market Today (Sept. 16, 2026): Nasdaq futures edge higher ahead of Fed decision
Why is the US Dollar firm when the Federal Reserve hike is already fully priced in?
5% Treasury yields mean America’s debt bill just got a lot bigger
US30 tests 52,140 as 5% Treasury yields rewrite the equity math
Rupee languishes at six-week low ahead of Fed outcome, RBI limits losses
Dow Jones Futures Rise As ServiceNow, Twilio Lead 8 New Buys; How Will Bonds React To Fed Hike?
Related Stocksin Laboratory Instruments
Ready to see the live AI view on BIO.B?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing BIO.B side-by-side with live signals.